Royalty Pharma IPO prices at top of range in biggest 2020 U.S. listing -sources

Royalty Pharma is set to sell shares in its U.S. initial public offering (IPO) at the top end its target range, in the biggest U.S. listing of the year so far, according to people familiar with the matter.

from Reuters: Company News https://ift.tt/2zDVa7y